Clearmind Medicine (CWY1) Financial Statements
Clearmind Medicine Financial Overview
Clearmind Medicine's market cap is currently $2.82M. The company's EPS TTM is $-89.20; its P/E ratio is -0.07; Clearmind Medicine has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Oct 25 | Oct 24 | Oct 23 | Jan 23 | Jan 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -49.36K | $ -51.07K | $ -57.43K | $ -119.62K | $ -2.53K |
| Operating Income | $ -5.67M | $ -5.74M | $ -6.29M | $ -9.00M | $ -3.61M |
| EBITDA | $ -3.72M | $ -4.79M | $ -8.53M | $ -9.75M | ― |
| Net Income | $ -3.86M | $ -5.25M | $ -8.61M | $ -9.93M | $ -3.66M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.58M | $ 9.55M | $ 5.51M | $ 437.77K | $ 3.71M |
| Total Assets | $ 6.08M | $ 10.10M | $ 5.95M | $ 1.12M | $ 4.16M |
| Total Debt | $ 1.78M | $ 73.97K | $ 0.00 | $ 52.11K | $ 0.00 |
| Net Debt | $ -2.14M | $ -9.08M | $ -5.43M | $ -122.68K | $ -3.71M |
| Total Liabilities | $ 4.89M | $ 5.77M | $ 4.97M | $ 2.62M | $ 288.19K |
| Stockholders' Equity | $ 1.19M | $ 4.33M | $ 983.47K | $ -1.50M | $ 3.87M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.73M | $ -6.76M | $ -6.30M | $ -5.06M | $ -2.25M |
| Operating Cash Flow | $ -4.73M | $ -6.76M | $ -6.30M | $ -5.06M | $ -2.08M |
| Investing Cash Flow | $ -541.97K | $ -331.43K | $ -26.23K | $ -7.55K | $ -184.03K |
| Financing Cash Flow | $ 2.62M | $ 8.71M | $ 11.66M | $ 694.52K | $ 5.39M |
Currency in CAD